APA (7th ed.) Citation

HL, C., CN, L., CH, C., MW, L., MC, T., SC, M., . . . MH, C. (2024). Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes. Liver international : official journal of the International Association for the Study of the Liver, 44(6), 1422. https://doi.org/10.1111/liv.15873

Chicago Style (17th ed.) Citation

HL, Chen, et al. "Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate in Pregnancy to Prevent HBV Transmission: Maternal ALT Trajectory and Infant Outcomes." Liver International : Official Journal of the International Association for the Study of the Liver 44, no. 6 (2024): 1422. https://doi.org/10.1111/liv.15873.

MLA (9th ed.) Citation

HL, Chen, et al. "Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate in Pregnancy to Prevent HBV Transmission: Maternal ALT Trajectory and Infant Outcomes." Liver International : Official Journal of the International Association for the Study of the Liver, vol. 44, no. 6, 2024, p. 1422, https://doi.org/10.1111/liv.15873.